Introduction
============

The recovery of spontaneous circulation (ROSC) after cardiac arrest results in a whole body ischemia-reperfusion syndrome called \'post-cardiac arrest syndrome\' \[[@B1],[@B2]\]. Post-cardiac arrest syndrome is a unique pathophysiological process that involves multiple organs including post-cardiac arrest brain injury, post-cardiac myocardial dysfunction, systemic ischemia/reperfusion response and persistent precipitating pathophysiology \[[@B1]\]. Post-cardiac arrest syndrome resembles multiorgan failure or septic shock but with a more comprehensive meaning. Immediately after ROSC, the heart rate and blood pressure are very unstable. Most patients need inotropics and vasopressors to manage hypotension due to impaired vasoregulation, myocardial dysfunction, and volume depletion. Also, the possibility of multi-organ failure and infection is increased because of systemic inflammatory immune responses and activation of the coagulation cascade \[[@B3],[@B4]\]. In this study, several serum hormonal concentrations, including cortisol, adrenocorticotropic hormone (ACTH), and anti-diuretic hormone (ADH (vasopressin)) were analyzed in relation to mortality and neurologic outcome upon ROSC after cardiac arrest.

Materials and methods
=====================

Study population
----------------

The study institution is a 1,300-bed university hospital with an annual emergency intensive care unit (EICU) census of 1,000. This was a retrospective study of patients with ROSC (\>24 hours) after cardiac arrest who were admitted to the EICU over a 34-month period between March 2007 and December 2009. The basal characteristics of the patients and the hormonal concentrations (cortisol, ACTH, and ADH) were obtained from laboratory results in their medical records. The patients with underlying hormonal disease (adrenal insufficiency and diabetes insipidus), patients who had already received cortisol and ADH, patients who died within 24 hours of admission, patients who received trauma and patients who were pregnant were excluded. This study was approved by the institutional review board of our center. Informed consent of blood sampling and study was obtained from the next of kin of the patients following the protocol used in our department.

Clinical evaluation and outcomes
--------------------------------

The basal characteristics of patients and outcomes were evaluated. Mortality and neurologic outcomes (Cerebral Performance Category (CPC)) were evaluated. We divided the patients into the following three groups: 1) survivors and non-survivors one week after admission (shock-related mortality); 2) survivors and non-survivors one month after admission (late dead from neurological dysfunction including brain death or cardiovascular problem including myocardial infarction and so on); and 3) good CPC (1, 2) and poor CPC (3 to 5) one month after admission.

Laboratory variables
--------------------

The serum cortisol, ACTH, and ADH levels were measured on the first morning after admission to the EICU (between 12 and 24 hours after ROSC). Tetracosactrin (250 μg, Synacthene^®^, NORVATIS, Australia) was administered intravenously and blood samples were obtained immediately before injection, and 30 and 60 minutes after injection. The hormonal concentrations were measured by chemiluminescence immunoassay (CLIA). Relative adrenal insufficiency was defined as an increase in serum cortisol of ≤9 μg/dL.

Statistical analysis
--------------------

The data were analyzed using SPSS software (version 16.0; SPSS, Inc., Chicago, IL, USA). A t-test and chi-square test were used and single and multiple variable logistic regression model analyses were performed to estimate the odds ratios of dying, along with 95% confidence intervals (CIs). Statistical significance was defined as a *P-*value \< 0.05.

Results
=======

The basal characteristics of the patients are shown in Table [1](#T1){ref-type="table"}. A total of 117 patients were evaluated in this study; there were 84 males (71.8%). Forty-nine (41.9%) patients had relative adrenal insufficiency on the first morning after admission to the EICU. One week and one month after admission, 87 (74.4%) and 65 patients (55.6%) survived, respectively. Thirty-five patients (29.9%) had a good CPC.

###### 

Basal characteristics of the patients (N = 117, median (IQR))

  ------------------------------ ------------------------
  Gender, M, n (%)               84 (71.8)
  Age (yr)                       52(44 to 64)
  BLS time (minutes)             5 (2 to 10)
  Arrest time (minutes)          36 (21 to 51)
  Epinephrine (mg)               3 (2 to 8)
  HTN, yes, n (%)                33 (28.2)
  DM, yes, n (%)                 13 (11.1)
  APACHE II                      23 (20 to 27)
  SOFA                           10 (8 to 11)
  Lactate (mmol/L)               8.7 (6.6 to 11.8)
  Cortisol, basal (μg/dL)        24.91 (15.00 to 37.36)
  Cortisol, 30 minutes (μg/dL)   28.73 (22.71 to 40.19)
  Cortisol, 60 minutes (μg/dL)   29.56 (23.49 to 42.76)
  RAI, Yes, n (%)                49 (41.9%)
  ACTH (pg/mL)                   5.40 (1.24 to 23.94)
  ADH (pg/mL)                    22.11 (12.42 to 35.19)
  Survivors, at 1 wk             87 (74.4%)
  Survivors, at 1 mo             65 (55.6%)
  CPC, good, n (%)               35 (29.9%)
  ------------------------------ ------------------------

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone, vasopressin; APACHE, Acute Physiology and Chronic Health Evaluation; BLS, basic life support; CPC, cerebral performance category (good CPC: 1 to 2, poor CPC: 3 to 5).

DM, diabetes mellitus; HTN, hypertension; SOFA, The Sequential Organ Failure Assessment; RAI, relative adrenal insufficiency.

The hormonal concentrations by mortality and neurologic outcomes are shown in Table [2](#T2){ref-type="table"}. The basal cortisol concentration was not significantly related to mortality one week and one month after admission, or CPC score, but the ACTH and ADH concentrations were significantly related to mortality one week and one month after admission, and the CPC score (Table [2](#T2){ref-type="table"}).

###### 

Variables by RAI, mortality, and neurologic outcome (N = 117, median values)

                                 RAI         1 wk mortality   1 mo mortality   CPC                                                                                             
  ------------------------------ ----------- ---------------- ---------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  Gender, M, n (%)               49 (72.1)   35 (71.4)        0.940            62 (71.3)   22 (73.3)   0.828       49 (75.4)   35 (67.3)   0.335       31 (88.6)   53 (64.6)   0.008\*
  Age (yr)                       52          53               0.772            52          54          0.422       49          56          0.174       47          56          0.010\*
  BLS time (minutes)             6           4                0.076            5           6           0.093       5           6           0.207       4           6           0.200
  Arrest time (minutes)          40          27               0.004\*          31          50          \<0.001\*   25          44          \<0.001\*   25          38          0.010\*
  Epinephrine (mg)               5           2                \<0.001\*        3           7           0.001\*     3           5           0.004\*     3           4           0.338
  HTN, yes, n (%)                18 (26.5)   15 30.6)         0.507            22 (25.3)   11 (36.7)   0.194       18 (27.7)   15 (28.8)   0.804       9 (25.7)    24 (29.3)   0.668
  DM, yes, n (%)                 6 (8.8)     7 (14.3)         0.283            8 (9.2)     5 (16.7)    0.298       5 (7.7)     8 (15.4)    0.152       1 (2.9)     12 (14.6)   0.102
  APACHE II                      23          22               0.889            22          27          0.001\*     22          26          \<0.001\*   31          26          \<0.001\*
  SOFA                           10          9                0.062            9           12          \<0.001\*   9           11          0.001\*     9           10          0.029\*
  Lactate (mmol/L)               9.40        7.55             0.013\*          8.50        9.40        0.244       8.40        9.35        0.190       8.30        8.90        0.393
  Cortisol, basal (μg/dL)        27.33       16.70            \<0.001\*        25.05       24.10       0.762       22.74       25.57       0.204       20.45       25.95       0.030\*
  Cortisol, 30 minutes (μg/dL)   28.74       28.54            0.543            28.89       27.35       0.380       28.29       29.54       0.584       26.45       29.32       0.273
  Cortisol, 60 minutes (μg/dL)   29.12       32.46            0.100            29.67       24.64       0.154       29.20       30.74       0.946       29.02       31.53       0.572
  ACTH (μg/dL)                   7.85        2.12             0.006\*          2.60        11.79       0.005\*     2.35        9.41        0.002\*     2.31        7.85        0.014\*
  ADH (pg/mL)                    24.97       17.11            0.031\*          19.81       28.65       0.037\*     18.16       28.27       0.004\*     14.42       24.80       0.001\*

\**P*\< 0.05

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone, vasopressin; APACHE, Acute Physiology and Chronic Health Evaluation; BLS, basic life support; CPC, cerebral performance category (good CPC: 1 to 2, poor CPC: 3 to 5); DM, diabetes mellitus; HTN, hypertension; RAI, relative adrenal insufficiency; SOFA, The Sequential Organ Failure Assessment.

Multiple logistic regression by mortality and CPC are shown in Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}. Relative adrenal insufficiency was significantly related to mortality one week after admission by multiple logistic regression analysis (odds ratio (OR), 2.601 and 95% confidence interval (CI), 1.015 to 6.664), but not significantly related to mortality one month after admission and CPC. ACTH was related to mortality one week after admission, but not to others. ADH was related to mortality one week and one month after admission, and CPC based on multiple logistic regression analysis.

###### 

Multiple logistic regression for mortality (at one week after admission)

  Factors         *P-*value   Odds ratio   95% CI of odds ratio   Observed power   
  --------------- ----------- ------------ ---------------------- ---------------- -------
  Age ≧50 yr      0.221       1.784        0.705                  4.510            0.261
  RAI (+)         0.046       2.601        1.015                  6.664            0.371
  ACTH ≧5 pg/mL   0.038       2.759        1.060                  7.185            0.428
  ADH ≧30 pg/mL   0.038       2.576        1.051                  6.313            0.343

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone; RAI, relative adrenal insufficiency.

###### 

Multiple logistic regression for mortality (at one month after admission)

  Factors         *P-*value   Odds ratio   95% CI of odds ratio   Observed power   
  --------------- ----------- ------------ ---------------------- ---------------- -------
  Age ≧50 yr      0.008       3.217        1.348                  7.680            0.770
  ACTH ≧5 pg/mL   0.054       2.265        0.987                  5.198            0.499
  ADH ≧30 pg/mL   0.008       3.463        1.389                  8.635            0.787

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone.

###### 

Multiple logistic regression for bad CPC (at one month after admission)

  Factors         *P-*value   Odds ratio   95% CI of odds ratio   Observed power   
  --------------- ----------- ------------ ---------------------- ---------------- -------
  Age ≧50 yr      0.001       4.564        1.794                  11.612           0.914
  ACTH ≧5 pg/mL   0.110       2.125        0.843                  5.356            0.346
  ADH ≧30 pg/mL   0.003       6.568        1.918                  22.483           0.891

ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone; CPC, Cerebral performance category.

Discussion
==========

Cardiac arrest is an extremely stressful condition, but few studies have investigated the hormonal response after a cardiac arrest. Post-cardiac arrest syndrome shares many features with severe sepsis or shock, including plasma cytokine elevation with deregulated cytokine production, the presence of endotoxin in plasma, coagulation abnormalities, and adrenal dysfunction \[[@B1],[@B5]\]. Post-cardiac arrest syndrome is a mixed condition of systemic inflammatory responses, hypovolemia, and myocardial dysfunction. During severe illness, including cardiac arrest, many factors can impair the normal hormonal response affecting the hypothalamic-pituitary-adrenal axis \[[@B6]\].

ADH is essential for cardiovascular homeostasis and release from the hypothalamus \[[@B7]\]. ADH synthesis is primarily mediated by variations in plasma effective osmolality and in blood volume or pressure. Landry *et al.*\[[@B8]\] reported that patients in septic shock indicated inappropriately low plasma ADH levels and an increased pressor sensitivity to exogenous ADH. Relative ADH deficiency may contribute to vasodilatory shock in sepsis, likely because of impaired baroreflex-mediated hormone secretion \[[@B9],[@B10]\]. Sharshar *et al.*\[[@B11]\] determined the serum ADH levels in patients with septic shock; serial plasma ADH levels were obtained at baseline, and 6, 24, 48, and 96 hours after the onset of shock. The study showed that plasma ADH levels are increased in nearly all cases during the initial phase of septic shock, and decreased thereafter. A relative ADH deficiency is more likely to occur 36 hours from the onset of shock \[[@B11]\]. Thus, the time at which ADH is measured in relation to the onset of shock is important. In the current study, the hormonal concentrations were measured on the first morning after ICU admission (12 to 24 hours after ROSC). The optimal timing for obtaining the basal and post-stimulation serum cortisol concentrations was recommended at that time, and this was helpful in estimating a prognosis of post-resuscitation disease \[[@B12]\]. Jochberger *et al.*\[[@B13]\] reported that serum ADH concentrations in patients after cardiac surgery (n = 96; 19.5 ± 30.4 pg/mL) were significantly higher than patients with sepsis (n = 25; 6.5 ± 4.3 pg/mL), and patients admitted for non-surgical diseases (n = 51; 6.5 ± 4.3 pg/mL; *P*\< 0.001). Leclere *et al.*\[[@B14]\] reported that the median ADH concentration in children with meningococcal septic shock was 41.6 pg/mL and was higher in non-survivors, but not significantly higher. In the current study, we divided the patients into two groups based on the ADH concentration. An ADH concentration \>30 pg/mL was associated with a two- to three-fold increased risk of bad outcomes (early and late deaths or poor CPC) based on multiple logistic regression analysis. The basal cortisol concentration was increased initially and not significantly associated with mortality and CPC, but relative adrenal insufficiency was related to early death (within one week following admission). The patients with an ACTH level \>5 pg/mL had a three-fold increased risk of early death. Based on the results of the current study, we suggest that within 24 hours of ROSC after cardiac arrest, the cortisol, ACTH, and ADH levels are immediately secreted from hypothalamic-pituitary-adrenal activation following an extremely stressful condition. An adequate initial endogenous stress response may correlate with recovery or even subsequent survival \[[@B13]\]. Hekimian *et al.*\[[@B15]\] reported that patients who die of early refractory shock after cardiopulmonary resuscitation may have an inadequate adrenal response to the stress. Relative adrenal insufficiency was related to poor prognosis or increased mortality rate in patients with resuscitation after cardiac arrest \[[@B12],[@B16]\]. The patients with relatively rapid onset adrenal insufficiency, higher plasma ACTH and ADH levels are related to death, and high concentrations of ADH are also related to bad neurologic outcomes. Because these patients have high concentrations of hormones already, the replacement of hormones, including cortisol and vasopressin, is uncertain. ADH did not reduce the mortality rates as compared with other drugs among patients with septic shock, and ADH did not have a benefit over other drugs in increasing survival to discharge or improving neurologic outcomes in patients after cardiac arrest \[[@B17],[@B18]\].

Our study had the following limitations. First, this was a retrospective, one-center study. Second, the sample sizes were small. Third, hormonal responses are very complicated. Variable factors could affect the hormonal responses in our study.

Conclusions
===========

The patients with relative adrenal insufficiency and higher blood levels of ACTH and ADH upon ROSC after cardiac arrest had a poor outcome. The effectiveness of administration of cortisol and ADH to patients upon ROSC after cardiac arrest is uncertain; additional studies are needed.

Key messages
============

• The axis of the hypothalamic-pituitary-adrenal gland was activated in patients with ROSC after cardiac arrest.

• The patients with relative adrenal insufficiency, still higher ACTH and ADH had a poor outcome.
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